Nevro Corp. (NYSE:NVRO – Get Free Report) has earned a consensus rating of “Reduce” from the thirteen research firms that are ...
In recent months, several firms have downgraded their ratings or lowered their price targets for Nevro stock. These adjustments reflect concerns about the company's ability to reverse the trend of ...
Nevro (NVRO ... of $116.18 million. The company has topped consensus revenue estimates three times over the last four quarters. The sustainability of the stock's immediate price movement based ...
Management uses certain non-GAAP financial measures, most specifically adjusted EBITDA, as a supplement to GAAP financial measures to further evaluate the Company's operating performance period ...
REDWOOD CITY, Calif. (AP) — REDWOOD CITY, Calif. (AP) — Nevro Corp. (NVRO) on Tuesday reported a loss of $53.1 million in its fourth quarter. On a per-share basis, the Redwood City, California ...
March 4, 2025 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical ... changes in fair market value of warrants, stock-based compensation, impairment of goodwill and depreciation and ...
Nevro Corp. (NVRO) on Tuesday reported a loss of $53.1 million in its fourth quarter. On a per-share basis, the Redwood ...
March 4, 2025 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical ... changes in fair market value of warrants, stock-based compensation, impairment of goodwill and depreciation and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback